• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Molecular Biology Division

    ​​​
     

    T​his Division quickly identifies and then characterizes newly emerging and reemerging infectious agents to  determine the genetic relatedness and distribution patterns of specific strains of  pathogens of public health importance in support of disease outbreak investigations and surveillance programs, monitors anti-viral/microbial drug resistance, and works closely with local, state and federal agencies to identify suspected agents of bioterrorism using molecular-based testing technologies such as...


    • Nucleic acid amplification assays (real-time PCR) 
    • PFGE pulsed-field gel electrophoresis (DNA 'fingerprinting')
    • Advanced DNA Sequencing Technologies (Next-Gen/Whole Genome Sequencing)
    • Time resolved fluorescence
     
     
     

    Division Chief: Robert A. Myers, Ph.D. 

    Office: 443-681-3800
    Fax: 443-681-4504

    Division Manager: Paul Stamper, M.S.P.H.​​

    Office: 443-681-3870


    Applied Research & Development Program:

    Developmental Scientist IIJenny Chen, M.S.​ 

    Office: 443-681-3921

    Developmental Scientist IIEric Keller, B.S. 

    Office: 443-681-4595​

    Developmental Scientist II: ​Garima Verma, Ph.D.

    Office: 443-681-3874​

    Principal Developmental Scientist: ​Victoria Campodónico, MD, PhD, D(ABMM)

    Office: 443-681-3940

    Biowatch Laboratory

    Laboratory Scientist Supervisor: Anish Patel, M.S.
    Office: 443-681-3875

    Lab: 443-681-4562​

    Core Sequencing

    Laboratory Scientist SupervisorTerence Moore
    Office: 443-681-3922

    Laboratory Scientist LeadNeil Chapel​
    Office: 443-681-3881

    The Core Sequencing Laboratory performs next generation sequencing on viral, bacterial, and fungal pathogens of human health concern.  The data created is used for outbreak detection and investigation, antimicrobial drug resistance monitoring, and pathogen identification.


    HIV Diagnostics/Disease Assessment Laboratory

    Laboratory Scientist Supervisor: Mark Massey
    Office: 443-681-3872

    Laboratory Scientist LeadMatt Stielper
    Office: 443-681-3877

    Instructions- Serological Testing Form with HIV​

    Unit processes specimens for HIV screening and confirmation (Antigen/Antibody, molecular testing).
    Unit processes specimens to monitor HIV treatment-Lymphocyte Immunophenotyping (flow cytometry, CD4, CD8 enumeration) and HIV-1 viral load. Special permission must be obtained before sending specimens for this testing.


    Molecular Diagnostics/Bioterrorism Laboratory

    Lab: 443-681-3924
    Fax: 443-681-3899/4504

    Laboratory Scientist Supervisor: Alex Kim, B.S.
    Office: 443-681-3923

    Molecular Diagnostic Lead ScientistChristina Taylor
    Office: 443-681-3920

    Molecular Bioterrorism Lead ScientistSalimatu Lukula, M.S.

    Office: 443-681-3905

    Run molecular based assays (qPCR, RT-qPCR, etc.) to detect pathogens, agents, and toxins of interest. Provide both clinical diagnostic and epidemiological surveillance data, with local and Federal partners, to help monitor the overall health of Maryland and its residence.


    Molecular Epidemiology Laboratory

    Laboratory Scientist Supervisor: ​Vacant
    Office: 443-681-3873

    Laboratory Scientist Lead: John Thoguru
    Office: 443-681-3880

    Immediate response to State and National Outbreak. Regional Laboratory CDC's Antimicrobial Resistance Laboratory Network (ARLN) See webpage Antibiotic Resistance Laboratory Network (ARLN).
    Carbapenem-resistant Enterobacterales (CRE) colonization and isolate testing.
    Carbapenem-resistant Acinetobacter baumannii (CRAB) colonization and isolate testing.
    Candida auris colonization and isolate testing.